Product
Lacosamide
Aliases
Lacosamide intravenous, Lacosamide oral, Lacosamide Oral Solution, Lacosamide Tablet (3 other aliases)
Name
Lacosamide Oral Solution
INN Name
lacosamide
FDA Approved
Yes
19 clinical trials
2 organizations
39 indications
1 document
Indication
EpilepsyIndication
Neonatal SeizuresIndication
Painful Diabetic NeuropathyIndication
Drug EffectIndication
Migraine DisordersIndication
Chronic PainIndication
Chronic Pain SyndromeIndication
Chronic PancreatitisIndication
HyperalgesiaIndication
Opioid Use DisorderIndication
Opioid-Related DisordersIndication
Opioid DependenceIndication
Chronic Abdominal PainIndication
ERCPIndication
Pancreatic SurgeryIndication
autoimmune encephalitisIndication
SeizureIndication
Opioid-induced Respiratory DepressionIndication
Alzheimer DiseaseIndication
GliomaIndication
Brain GliomaIndication
Brain TumorIndication
Neuropathic PainIndication
Neuropathy PeripheralIndication
NeuropathyIndication
PainIndication
DiabetesIndication
Traumatic Brain InjuryIndication
AcuteIndication
TraumaIndication
Cerebral IschemiaIndication
Brain HypoxiaIndication
Hypoxic-ischemic encephalopathyIndication
BrainIndication
Cardiac ArrestIndication
strokeIndication
Intracranial HemorrhageIndication
ComaIndication
Vegetative StateClinical trial
An Open-label, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Lacosamide as Adjunctive Therapy for Uncontrolled Primary Generalized Tonic-Clonic Seizures in Subjects With Idiopathic Generalized EpilepsyStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
A Multicenter, Open-Label, Randomized, Active Comparator Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal SeizuresStatus: Recruiting, Estimated PCD: 2025-08-04
Clinical trial
A Multicenter, Open-label, Follow-up Study to Assess the Long-term Use of Lacosamide (Flexible Dose From 200 to 600 mg/Day) Used as Monotherapy in Subjects Who Completed SP0994 and Received Lacosamide Monotherapy TreatmentStatus: Completed, Estimated PCD: 2020-01-01
Clinical trial
A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide in Children (>= 1 Month to < 17 Years of Age) With EpilepsyStatus: Completed, Estimated PCD: 2019-06-28
Clinical trial
An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.Status: Not yet recruiting, Estimated PCD: 2023-06-30
Clinical trial
A Multicenter, Open-label Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic NeuropathyStatus: Completed, Estimated PCD: 2007-10-31
Clinical trial
A Multicenter, Open-label, Long-term Extension Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Pediatric Subjects With Epilepsy With Partial-Onset SeizuresStatus: Completed, Estimated PCD: 2022-04-13
Clinical trial
a Randomized Pilot Study of Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine PatientsStatus: Completed, Estimated PCD: 2023-08-09
Clinical trial
A Multi-center, Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-blind, Randomized Time Point Withdrawal Subtrial.Status: Completed, Estimated PCD: 2011-01-01
Clinical trial
A Multicenter, Open-Label, Follow-Up Study to Assess the Long-Term Use of Oral Lacosamide in Study Participants Who Completed EP0034 or SP848 and Received Lacosamide TreatmentStatus: Active (not recruiting), Estimated PCD: 2025-07-31
Clinical trial
Safety and Efficacy of Lacosamide Versus Propranolol in MigraineStatus: Completed, Estimated PCD: 2023-07-30
Clinical trial
Lacosamide Versus Topiramate in Migraine, a Ranodmized TrialStatus: Recruiting, Estimated PCD: 2025-02-02
Clinical trial
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic PancreatitisStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Multicenter Clinical Study of Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated EpilepsyStatus: , Estimated PCD: 2025-05-31
Clinical trial
Combined Effect of Pregabalin and Oxycodone, and Lacosamide and Oxycodone, on Breathing: an Exploratory Study in Healthy Volunteers (The Polo Study)Status: Completed, Estimated PCD: 2024-01-12
Clinical trial
A Clinical Study Exploring Lacosamide and Levetiracetam in Improving Cognitive in Patients With Alzheimer's Disease and EpilepsyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Phase II Trial of Seizure Prophylaxis in Brain Tumor Patients Undergoing Neurosurgical ProcedureStatus: Terminated, Estimated PCD: 2020-12-04
Clinical trial
The Effect of Lacosamide in Peripheral Neuropathic Pain: a Randomized, Double-blind, Placebo Controlled, Phenotype-stratified StudyStatus: Terminated, Estimated PCD: 2022-06-03
Clinical trial
Effect of Antiseizure Medication in Seizure Networks at Early Stages of Acute Brain Injury. The Rs-fMRI, Open-label Pilot TrialStatus: Recruiting, Estimated PCD: 2024-11-01
Organization
Ascend Laboratories, LLCOrganization
Apotex Corp.